195 related articles for article (PubMed ID: 35703361)
1. Development of a cancer cells self‑activating and miR‑125a‑5p expressing poly‑pharmacological nanodrug for cancer treatment.
Chang YC; Shieh MC; Chang YH; Huang WL; Su WC; Cheng FY; Cheung CHA
Int J Mol Med; 2022 Aug; 50(2):. PubMed ID: 35703361
[TBL] [Abstract][Full Text] [Related]
2. miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer.
Li D; Chen L; Zhang X; Wang Y; Huang C; Li J; He F; He W
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34549308
[TBL] [Abstract][Full Text] [Related]
3. The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells.
Chang YC; Kondapuram SK; Yang TH; Syed SB; Cheng SM; Lin TY; Lin YC; Coumar MS; Chang JY; Leung E; Cheung CHA
Toxicol Appl Pharmacol; 2020 Aug; 401():115080. PubMed ID: 32497533
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
6. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
7. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑125a‑5p regulates liver cancer cell growth, migration and invasion and EMT by targeting HAX1.
Zha Z; Li J
Int J Mol Med; 2020 Nov; 46(5):1849-1861. PubMed ID: 33000203
[TBL] [Abstract][Full Text] [Related]
9. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
10. Image-guided breast tumor therapy using a small interfering RNA nanodrug.
Kumar M; Yigit M; Dai G; Moore A; Medarova Z
Cancer Res; 2010 Oct; 70(19):7553-61. PubMed ID: 20702603
[TBL] [Abstract][Full Text] [Related]
11. CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.
Zhang L; Li Y; Hu C; Chen Y; Chen Z; Chen ZS; Zhang JY; Fang S
Mol Cancer; 2022 Apr; 21(1):103. PubMed ID: 35459184
[TBL] [Abstract][Full Text] [Related]
12. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
13. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.
Xu X; Chen X; Xu M; Liu X; Pan B; Qin J; Xu T; Zeng K; Pan Y; He B; Sun H; Sun L; Wang S
Aging (Albany NY); 2019 Sep; 11(18):7357-7385. PubMed ID: 31543507
[TBL] [Abstract][Full Text] [Related]
14. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
[TBL] [Abstract][Full Text] [Related]
15. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
16. lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR‑125a‑5p.
Liu Y; Li M; Yu H; Piao H
Int J Mol Med; 2020 Feb; 45(2):497-509. PubMed ID: 31894257
[TBL] [Abstract][Full Text] [Related]
17. BPR1K653, a novel Aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells.
Cheung CH; Lin WH; Hsu JT; Hour TC; Yeh TK; Ko S; Lien TW; Coumar MS; Liu JF; Lai WY; Shiao HY; Lee TR; Hsieh HP; Chang JY
PLoS One; 2011; 6(8):e23485. PubMed ID: 21887256
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
[TBL] [Abstract][Full Text] [Related]
19. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
[TBL] [Abstract][Full Text] [Related]
20. Propofol‑induced miR‑125a‑5p inhibits the proliferation and metastasis of ovarian cancer by suppressing LIN28B.
Zeng J; Li YK; Quan FF; Zeng X; Chen CY; Zeng T; Zou J; Tong WJ
Mol Med Rep; 2020 Aug; 22(2):1507-1517. PubMed ID: 32627014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
